TScan Therapeutics, Inc. (TCRX)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
Feb 20, 11:40
TScan Therapeutics Profit Margin (Quarterly) : -1.42K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| GT Biopharma, Inc. | -- |
| Sutro Biopharma, Inc. | -586.6% |
| Geron Corp. | -39.02% |
| SELLAS Life Sciences Group, Inc. | -- |
| Agios Pharmaceuticals, Inc. | -541.1% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.23% |
| Return on Assets | -44.21% |
| Return on Invested Capital | -48.24% |
| Gross Profit Margin (Quarterly) | 69.45% |
| Operating Margin (Quarterly) | -1.48K% |
| Return on Net Operating Assets | -204.2% |